Synagistics and China Post Hong Kong Join Forces to Expand AI-Driven Digital Commerce Platform & Trade Ecosystem Connecting China with Southeast Asia
Logistics Infrastructure to Strengthen Cross-Border Commerce and
Internationalization For China Brands
HONG KONG, July 18, 2025 /PRNewswire/ -- Synagie, Southeast Asia's leading AI-powered digital commerce platform, a subsidiary of Synagistics Limited Stock (HKEX: 2562.HK), announced today a strategic partnership with China Post Hong Kong Company Limited ("China Post Hong Kong"). The two parties will jointly build an integrated AI-driven Digital Commerce Platform & Trade Ecosystem offering automated and seamless solutions for China brands entering the Southeast Asian markets.
The strategic venture will focus on four core pillars: China brand internationalization, global logistics integration, cross-border e-commerce channel enablement, and AI and Big Data powered commerce and business intelligence. Together, the two companies aim to facilitate two-way trade between Mainland China, Hong Kong, and Southeast Asia, while addressing challenges such as fragmented regional supply chains, prohibitive fulfillment costs, and diverse consumer preferences.
Empowering the Belt and Road Digital Trade Landscape Accelerating the Rollout of the "China Brands Go-Global 100" Initiative
With Southeast Asia's demographic dividend unlocking, accelerating economic growth, and rapidly improving digital infrastructure, the region is emerging as one of the world's most dynamic hubs for e-commerce and the digital economy. According to forecasts, the region's e-commerce market is expected to surpass USD 295 billion by 2025, with an annual growth rate exceeding 20%, making it the fastest-growing digital trade market globally. Against this backdrop, building an efficient, interoperable cross-border logistics and digital operations framework is essential to enable two-way trade between China and Southeast Asia.
This partnership also supports the "China Brands Go-Global 100" (CBGG) initiative, jointly driven by China and Singapore as part of the China-Singapore Cross-Border Digital Innovation Drive (2025). The program aims to advance the globalization of Chinese brands, establish data-driven trade systems, and foster cross-border innovation through regional digital collaboration. With robust capabilities in cross-border logistics and AI-driven commerce infrastructure, the collaboration between Synagie and China Post Hong Kong will provide scalable and high-efficiency support for participating CBGG 100 brands—accelerating digital integration between China and Southeast Asia and shaping a new era of borderless trade.
Mr. Chen, Managing Director of China Post Hong Kong, said: "As global market dynamics accelerate, there is growing demand for efficient, stable, and agile cross-border logistics solutions. China Post Hong Kong is committed to leveraging Hong Kong's strategic position as a global gateway underpinned by Mainland China. Our collaboration with Synagie will enhance supply chain visibility and operational agility, helping brands achieve sustainable growth in increasingly complex markets. Through this partnership, we also seek to strengthen Hong Kong's role as a 'Super Connector' in regional supply chain coordination and digital trade development."
Key Collaboration Pillars: Building an AI + Logistics Cross-Border Ecosystem
1. China Brand Internationalization and Market Entry
China Post Hong Kong will leverage its extensive postal network and industry connections to identify and introduce high-quality brands from Mainland China and Hong Kong. Synagie will then support these brands with tailored land and expand strategies with localized digital commerce enablement across the Southeast Asia region.
2. Integrated Supply Chain and Logistics Solutions
Capitalizing on China Post Hong Kong's strength in international transportation, warehousing, and customs clearance, both parties will co-develop end-to-end logistics solutions connecting China and Southeast Asia to enhance cross-border delivery performance and boost supply chain efficiency.
3. Digital Commerce Channel Integration and Optimised Operational Support
Synagie's portfolio of global brands will be connected to China Post Hong Kong's official Douyin (TikTok China) stores and social commerce accounts, as well as to China Post's e-commerce platform, Youle. This integration, combined with China Post Hong Kong's expertise in content commerce and fulfillment, will deliver comprehensive operational support to participating brands.
4. AI-Driven Digital Commerce Platform & Trade Ecosystem
Synagie will harness its proprietary AI & Big Data platform to deliver real-time consumer insights, in-depth demand forecasting, and operational optimization solutions. Both parties will jointly offer Enterpise AI solutions to China Post Hong Kong's enterprise customers, to accelerate AI transformation for these businesses.
Ms. Olive Tai, Co-Founder and CEO of Synagistics, commented: "Southeast Asia is no longer just a destination for brand expansion, it's a dynamic, multidimensional competition around platform agility, supply chain responsiveness, and data-driven operations. Synagie is committed to building scalable, predictable infrastructure to help brands strike the right balance between speed and efficiency. Through this collaboration with China Post Hong Kong, we are deepening the integration between AI technology and logistics networks, empowering businesses with practical and adaptable cross-border solutions to support regional growth."
About Synagistics Limited (HKEX: 2562.HK)
Synagistics is a Singapore-based AI & big data company listed on the Main Board of The Stock Exchange of Hong Kong Limited, recognised for completing the first-ever De-SPAC transaction in Hong Kong. With Alibaba, Gobi Partners and Hong Kong Telecom as its key strategic shareholders, Synagistics benefits from strong industry backing, enabling it to drive innovation and expand its influence in Asia's rapidly evolving digital ecosystem. Synagistics is recognised as one of the top digital solutions provider in Southeast Asia and has provided its data-driven digital commerce platform Synagie to over 600 enterprises and renowned brands in the Southeast Asian market. With the launch of Geene in early March 2025, Synagistics has firmly established itself as a frontrunner in the rapidly evolving field of artificial intelligence, solidifying its position as a key leader in the global Al ecosystem and accelerating enterprise Al adoption and innovation. The Company continues to expand its footprint across multiple markets including the Greater China region while championing digital and artificial intelligence transformation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
2 hours ago
- Korea Herald
Samsung Biologics reports second quarter 2025 financial results
INCHEON, South Korea, July 23, 2025 /PRNewswire/ -- Samsung Biologics (KRX: a leading contract development and manufacturing organization (CDMO), today announced its financial results for the second quarter of fiscal year 2025. "Our second quarter results demonstrate continued strong momentum across our business," said John Rim, CEO and President of Samsung Biologics. "With Plant 5 now fully operational, we are leveraging our manufacturing expertise and expanded capacity to deliver seamless, end-to-end CDMO services at scale. We have broadened our portfolio with advancements in antibody-drug conjugates (ADCs) and the launch of research services, Samsung Organoids, further reinforcing our ability to offer a wider range of innovative solutions to clients. Additionally, we are redefining digitalization in biomanufacturing, harnessing advanced digital tools to deliver greater transparency, speed, and value—setting new standards in the industry. These strategic initiatives will continue to strengthen our ability to accelerate client pipelines, while fostering enduring partnerships grounded in quality and operational excellence." SECOND QUARTER 2025 RESULTS Samsung Biologics posted consolidated revenue of KRW 1,289.9 billion and operating profit of KRW 475.6 billion in the second quarter of 2025. On a standalone basis, the company reported revenue of KRW 1,014.2 billion and operating profit of KRW 477.0 billion. The growth was buoyed by the full utilization of Plants 1 through 3 and the continued ramp-up of Plant 4. In the first half of 2025, standalone revenue surpassed KRW 2 trillion, reflecting consistent momentum across all manufacturing plants. Sales contract volume in the first half reached USD 2.4 billion, bringing up the cumulative value to USD 18.7 billion. BUSINESS UPDATES In April, Samsung Biologics added 180 kL of capacity with Plant 5 to better meet clients' manufacturing needs. The facility, equipped with advanced automation and digital systems, integrates best practices and features from existing plants to ensure consistent operations and the highest quality standards. The company also broadened its service offering with the launch of research services, Samsung Organoids, which utilizes patient-derived organoids to support drug discovery and development. Samsung Organoids enables precision screening to predict patient-specific drug responses and provides clients with multi-modal insights to effectively support early-stage decision making. In May, Samsung Biologics announced plans to spin off its wholly-owned subsidiary, Samsung Bioepis. Through the financial and legal separation, the company will focus on strengthening its core capabilities as a pure-play CDMO, enhancing customer satisfaction and proactively responding to the industry's greater demands to ultimately maximize corporate value and sustainable growth potential. On the sustainability front, the company released its 2025 ESG report in June, outlining progress in areas including enhanced disclosure standards, an accelerated path to net-zero, and TNFD-aligned risk management. As part of its decarbonization efforts, Samsung Biologics achieved a 24% reduction in greenhouse gas emissions in 2024 compared to the previous year and increased its renewable energy use to 29% of total electricity consumption. The company also signed an additional solar Power Purchase Agreement to further support its energy transition. Beyond operations, Samsung Biologics is actively engaged in collaborative efforts through the Sustainable Market Initiative to decarbonize healthcare supply chains and promote global environmental responsibility. About Samsung Biologics Samsung Biologics (KRX: is a leading contract development and manufacturing organization (CDMO), offering end-to-end integrated services that range from late discovery to commercial manufacturing. With a combined biomanufacturing capacity of 784 kL across five plants, Samsung Biologics leverages cutting-edge technologies and expertise to advance diverse modalities, including multispecific antibodies, fusion proteins, antibody-drug conjugates, and mRNA therapeutics. Samsung Biologics operates a global network with facilities and offices in Korea, the U.S., and Japan. Samsung Biologics America supports clients based in the U.S. and Europe, while its Tokyo sales office serves the APAC region. Samsung Biologics continues to invest in new capabilities to maximize operational and quality excellence, ensuring flexibility and agility for clients. The company is committed to the on-time, in-full delivery of safe, high-quality products, as well as making sustainable business decisions for the betterment of society and global health.
Korea Herald
a day ago
- Korea Herald
Trump says Philippines will pay 19% 'reciprocal' tariffs
US President Donald Trump said Tuesday that the Philippines will pay 19 percent tariffs, a percentage point lower than what was previously announced, noting that the Southeast Asian nation will open its market to the United States. In a social media post, Trump said that his administration reached a trade deal with the Philippines, after he held a meeting with Philippine President Ferdinand Marcos Jr. at the White House. "We concluded our Trade Deal, whereby The Philippines is going OPEN MARKET with the United States, and ZERO Tariffs. The Philippines will pay a 19% Tariff," Trump wrote on Truth Social. "In addition, we will work together Militarily. It was a Great Honor to be with the President. He is Highly Respected in his Country, as he should be. He is also a very good, and tough, negotiator. We extend our warmest regards to the wonderful people of The Philippines!" The deal comes as South Korea and other countries are striving to strike trade deals with the US before Aug. 1, when Trump's "reciprocal" tariffs, including 25 percent duties on South Korea, are set to take effect. (Yonhap)
Korea Herald
a day ago
- Korea Herald
Nikko AM Introduces ChiNext ETF on Singapore Exchange under ETF Link, Tied to E Fund's Onshore ETF
GUANGZHOU, China, July 22, 2025 /PRNewswire/ -- On July 22, the China-Singapore ETF Link continues to expand with the listing of the Amova E Fund ChiNext Index ETF (ticker: CXT) on Singapore Exchange (SGX), launched by Nikko Asset Management (Nikko AM) in collaboration with E Fund Management (E Fund), the largest mutual fund manager in China, aiming to provide overseas investors with access to the growth potential of China's ChiNext market. The Amova E Fund ChiNext Index ETF is linked to the E Fund ChiNext ETF (ticker: 159915), which tracks the ChiNext Index—a key broad-based index of innovative and entrepreneurial companies listed on the Shenzhen Stock Exchange (SZSE). Over 90% of the index is weighted in strategic emerging industries such as next-generation information technology, new energy vehicles, and biotechnology, and includes leading companies like CATL, Inovance, InnoLight, Mindray, and Sungrow. The index constituents have demonstrated strong fundamentals, with compound annual growth rates of 21% in revenue and 14% in net profit since 2021. As of July 18, ETFs tracking the ChiNext Index held more than USD 16.3 billion in assets, led by the E Fund ChiNext ETF (ticker: 159915) accounting for USD 12 billion, which was also the first ETF to track the index. "As the world's second-largest economy, China has been steadily opening up its financial markets, becoming an essential part of global asset allocation," Yue Fan, Executive Vice President of E Fund, stated. "As a core flagship of SZSE, the ChiNext Index was launched in 2010, with constituents reflecting the driving forces of China's new economy - spanning innovative sectors such as semiconductors, artificial intelligence, new energy, and biopharmaceuticals. The Amova E Fund ChiNext Index ETF marks a milestone in China-Singapore financial collaboration, offering investors in Singapore and the broader region efficient access to China's new economy. We have a similar cross-border ETF partnership with Nikko AM in Japan, and this new ETF in Singapore highlights our deepening long-term partnership and shared vision for global market expansion." "Our collaboration with E Fund marks a significant milestone in cross-border ETF innovation. We are proud to partner with E Fund to channel our combined scale, deep expertise, and local insights into this ETF that is a powerful representation of China's entrepreneurial spirit and technological advancement. Together, we are offering investors a differentiated and forward-looking way to participate in China's innovation-led growth story," said Eleanor Seet, President and Director, Nikko Asset Management Asia Limited and Head of Asia ex-Japan, Nikko Asset Management. The listing brings the China-Singapore ETF Link program to 10 ETFs since its 2022 inception, demonstrating strengthened financial cooperation and improved cross-border investment access between both markets while offering greater convenience to investors across Asia-Pacific region and globally. About E Fund Established in 2001, E Fund is a leading comprehensive mutual fund manager in China with over RMB 3.6 trillion (USD 512 billion) under management as of 30 Jun 2025. It offers investment solutions to onshore and offshore clients, helping clients achieve long-term sustainable investment performances. E Fund's clients include both individuals and institutions, ranging from central banks, sovereign wealth funds, social security funds, pension funds, insurance and reinsurance companies, to corporates and banks. Long-term oriented, it has been focusing on the investment management business since inception and believes in the power of in-depth research and time in investing. It is a pioneer and leading practitioner in responsible investments in China and is widely recognized as one of the most trusted and outstanding Chinese asset managers. About Nikko AM With US$233.9 billion under management as of 31 March 2025, Nikko Asset Management is one of Asia's largest asset managers, providing high-conviction, active fund management across a range of equity, fixed income, multi-asset and alternative strategies. In addition, its complementary range of passive strategies covers more than 20 indices and includes some of Asia's leading exchange-traded funds (ETFs). Effective 1 September 2025, Nikko Asset Management will be known as Amova Asset Management.
